Gera, Germany: - High-potency active ingredient specialist CDMO HAPILA GmbH is returning to Europe’s leading pharma industry event, the CPHI 2023 trade expo, this year in Barcelona.
HAPILA will again be one of the leading presences in the API Zone, where its large stand at Booth 6C40 at the Fira Barcelona Gran Via exhibition complex will again be shared with its global marketing and distribution partner Transo-Pharm Handels GmbH.
Innovative APIs
The HAPILA displays will showcase its extensive portfolio of chemical synthesis and GMP-manufacturing capabilities as well as innovative APIs such as Estriol.
The HAPILA presence in Barcelona will again be led by its CEO, Dr. Uwe Müller, with a team that will cover all relevant areas of the 2023 expo, including its networking platforms and online dimension.
End-to-end solutions
Dr. Müller comments: “Our relationship with CPHI extends back to 2007 and we keep returning because it provides us with a superb platform to present our very considerable strengths in being able to provide end-to-end and one stop shop solutions for almost any API sourcing issue.”
“We can use the event to demonstrate that HAPILA has the high flexibility and wide technical know-how needed for all aspects of GMP-compliant development and manufacturing, our in-house quality control unit, and extensive portfolio that covers the whole spectrum from lab-scale to full-scale reactor processes.
